A carregar...
Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
INTRODUCTION: Deep remission, defined as clinical remission with mucosal healing (MH), with anti-tumor necrosis factor (TNF)-α agents is a new target for therapy in Crohn’s disease (CD). Provided that the efficacy of infliximab (IFX) for induction of MH in CD has been demonstrated, there are much le...
Na minha lista:
| Publicado no: | Prz Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5360663/ https://ncbi.nlm.nih.gov/pubmed/28337236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2016.64746 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|